ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/NSW/2999-Unspecified-Clinical-Trial-Site-NSW-GenesisCare
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
2
trial(s) found.
NCT06939036
Advanced
Phase 1 / Phase 2
Recruiting
A Multicentre, Open-label, Phase I/II Study Investigating the Safety, Tolerability, and Preliminary Efficacy of 225Ac-SSO110 in Participants With Extensive Stage Small Cell Lung Cancer (ES-SCLC) or Merkel Cell Carcinoma (MCC) Receiving Standard of Care (SoC) (
SANTANA-225
)
225Ac-SSO11
Atezolizumab
Avelumab
Durvalumab
Pembrolizumab
Retifanlimab
anti-PD-1 monoclonal antibody
anti-PD-L1 monoclonal antibody
cancer therapy
cancer therapy,PD-1-targeting
cancer therapy,PD-1/PD-L1-targeting
cancer therapy,PD-L1-targeting
immune checkpoint blockade
immune checkpoint blockade,PD-1-targeting
immune checkpoint blockade,PD-L1-targeting
immuno-oncology therapy,PD-1-targeting
immuno-oncology therapy,PD-L1-targeting
radioligand,SSTR2-targeting
Merkel cell carcinoma
Small-cell lung cancer
NSW
2999 - Unspecified - Clinical Trial Site NSW - GenesisCare
NCT04879329
Advanced
Phase 2
Recruiting
A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone or in Combination With Pembrolizumab in Subjects With Locally-Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2 (
RC48G001
)
anti-ERBB2 antibody-drug conjugate
anti-PD-1 monoclonal antibody
Urothelial carcinoma
NSW
2065 - St Leonards - GenesisCare North Shore Private Hospital
2109 - North Ryde - Macquarie University Hospital
2999 - Unspecified - Clinical Trial Site NSW - GenesisCare
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
4102 - Woolloongabba - Princess Alexandra Hospital
SA
5112 - Elizabeth Vale - Lyell McEwin Hospital
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (2)
Recruitment Country and State
NSW (2)
QLD (1)
SA (1)
VIC (1)
Phase
Phase 1 / Phase 2 (1)
Phase 2 (1)
Trial Type
Advanced (2)
Cancer Therapy Class
PD-1
100%
PD-1/PD-L1
100%
PD-L1
50%
ERBB2
50%
Facility
2999 - Unspecified - Clinical Trial Site NSW - GenesisCare (2)
2065 - St Leonards - GenesisCare North Shore Private Hospital (1)
2109 - North Ryde - Macquarie University Hospital (1)
3199 - Frankston - Peninsula Health Frankston Hospital (1)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
5112 - Elizabeth Vale - Lyell McEwin Hospital (1)
Cancer Type
Cancer
Solid tumour
Carcinoma
Lung cancer
Merkel cell carcinoma
Neuroendocrine carcinoma
Non-melanoma skin cancer
Respiratory tract cancer
Skin cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Thoracic cancer
Urogenital cancer
Urothelial carcinoma
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy